- Home
- TLRY vs SLRC Comparison
TLRY vs SLRC Comparison
Compare TLRY & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLRY | SLRC |
|---|---|---|
| Founded | N/A | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 919.2M | 803.0M |
| IPO Year | 2018 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TLRY | SLRC |
|---|---|---|
| Price | $6.89 | $13.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $103.33 | $15.58 |
| AVG Volume (30 Days) | ★ 2.3M | 308.8K |
| Earning Date | 04-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.70 |
| Revenue | N/A | N/A |
| Revenue This Year | $7.39 | $1.09 |
| Revenue Next Year | $4.76 | N/A |
| P/E Ratio | ★ N/A | $8.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $13.64 |
| 52 Week High | $15.70 | $17.26 |
Technical Indicators
Market Signals| Indicator | TLRY | SLRC |
|---|---|---|
| Relative Strength Index (RSI) | 36.52 | 32.05 |
| Support Level | $1.00 | N/A |
| Resistance Level | $8.20 | $15.52 |
| Average True Range (ATR) | 0.35 | 0.38 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 4.30 | 0.00 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
About SLRC SLR Investment Corp.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.